Report: Government's cancer-research network nears "a state of crisis"

04/16/2010 | Bloomberg

An analysis by the Institute of Medicine shows that 40% of Phase III clinical trials conducted by the Clinical Trials Cooperative Group Program, a unit of the National Cancer Institute, end up being terminated because of inefficiency and lack of funding. "If the clinical trial system does not improve its efficiency and effectiveness, the introduction of new treatments for cancer will be delayed and patient lives will be lost unnecessarily," according to the report.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT